PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Measures of Cancer Survival
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
Survival in oncology reimbursement decision-making | CMAR
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework | British Journal of Cancer
Progression Free Survival - an overview | ScienceDirect Topics
National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer | Journal of Clinical Oncology
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer
Frontiers | What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis
Endpoints in adjuvant trials: a systematic review of the literature in colon cancer and proposed definitions for future trials Marc E. Buyse. - ppt download
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
Time to second subsequent therapy as an endpoint. Progression-free... | Download Scientific Diagram